Long term results of EORTC trial for patients with resectable liver metastases from colorectal cancer
Long term results of the randomized phase III EORTC intergroup trial 40983 were recently reported in The Lancet Oncology. The observed 4.1% difference in overall survival at five years for patients with initially resectable liver ...
Nov 06, 2013
not rated yet | 0